prednimustine has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.00) | 18.7374 |
| 1990's | 18 (72.00) | 18.2507 |
| 2000's | 1 (4.00) | 29.6817 |
| 2010's | 2 (8.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, JY; Cho, EK; Cho, EY; Hong, J; Hwang, I; Lee, JH; Park, J; Park, S; Shin, DB | 1 |
| Diehl, V; Engert, A; Franklin, J; Hasenclever, D; Josting, A; Loeffler, M; Scholz, M | 1 |
| Björkholm, M; Engstedt, L; Gahrton, G; Ideström, K; Johansson, B; Killander, D; Kimby, E; Mellstedt, H; Robérts, KH; Stalfelt, AM; Udén, AM; Wadman, B; Wählby, S | 1 |
| Dreger, P; Haferlach, T; Klöss, M; Loeffler, M; Löffler, H; Petersen, B; Schmitz, N | 1 |
| Arcicasa, M; Bortolus, R; Carbone, A; De Paoli, A; Franchin, G; Pinto, A; Roncadin, M; Trovò, MG; Valeri, P; Zagonel, V | 1 |
| Carbone, A; Errante, D; Monfardini, S; Sorio, R; Talamini, R; Tirelli, U; Zagonel, V | 1 |
| Herrmann, R; Hiddemann, W; Koch, P; Nahler, M; Unterhalt, M | 1 |
| Baldetorp, L; Carstensen, J; Håkansson, L; Hatschek, T; Möller, T; Nilsson, B; Termander, B | 1 |
| Errante, D; Gastaldi, R; Magnani, G; Nigra, E; Nosari, AM; Spina, M; Tirelli, U; Vaccher, E | 1 |
| Bodenstein, H; Dietzfelbinger, H; Eimermacher, H; Engert, A; Freund, M; Herrmann, R; Hiddemann, W; Kreuser, ED; Landys, K; Nahler, M; Neubauer, A; Parwaresch, R; Reuss-Borst, M; Stauder, R; Stein, H; Tiemann, M; Tirier, C; Trümper, L; Unterhalt, M | 1 |
| Bron, D; Errante, D; Kluin-Nelemans, JC; Noordijk, EM; Rosti, G; Somers, R; Teodorovic, I; Thomas, J; Tirelli, U; Van Glabbeke, M; Zagonel, V | 1 |
| Busch, M; Freund, M; Hanrath, RD; Helm, G; Herrmann, R; Hiddemann, W; Kaiser, U; Kreuser, ED; Middeke, H; Neubauer, A; Parwaresch, R; Reuss-Borst, M; Stein, H; Terhardt-Kasten, E; Tiemann, M; Trümper, L; Unterhalt, M; Wöltjen, HH | 1 |
| Colomer, R; Gómez, H | 1 |
| Burns, BF; Cripps, C; Germond, C; Gluck, S; Goss, GD; Koski, TM; Lister, DC; Verma, S; Yau, JC | 1 |
| Barbarano, L; Bernuzzi, P; Gargantini, L; Morra, E; Nosari, A; Pungolino, E; Santoleri, L | 1 |
| Freund, M; Hanauske, AR; Hiddemann, W; Link, H; Poliwoda, H; Schäfers, M; Schmoll, HJ; Seidel, I; Wunsch-Zeddies, S; Wysk, J | 1 |
| Carbone, A; De Cicco, M; Errante, D; Monfardini, S; Serraino, D; Talamini, R; Tirelli, U; Zagonel, V | 1 |
| Herrmann, R; Hiddemann, W; Koch, P; Nahler, M; Unterhalt, M; van de Loo, J | 1 |
| Loos, U; Malek, M; Musch, E; Riedel, E | 1 |
| Hiddemann, W; Koch, P; Nahler, M; Unterhalt, M; van de Loo, J | 1 |
| Carbone, A; Errante, D; Monfardini, S; Morassot, S; Sorio, R; Tirelli, U; Zagonel, V | 1 |
| Brousse, N; Herrera, A; Peuchmaur, M; Solal-Celigny, P; Tertian, G | 1 |
| Eckhardt, S; Fleischmann, T; Szántó, I | 1 |
| Landys, KE | 1 |
| Canetta, R; Carbone, A; Tirelli, U; Veronesi, A; Zagonel, V | 1 |
1 review(s) available for prednimustine and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
[Treatment of lymphoma in the aged].
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Palliative Care; Prednimustine; Prednisolone; Prednisone; Prognosis; Vincristine | 1998 |
13 trial(s) available for prednimustine and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
Topics: Adult; Aged; Chlorambucil; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednimustine; Prednisolone; Prospective Studies | 1982 |
Total body irradiation and prednimustine in chronic lymphocytic leukemia and low grade non-Hodgkin's lymphomas. A 9-year experience at a single institution.
Topics: Age Factors; Aged; Aged, 80 and over; Combined Modality Therapy; Drug Administration Schedule; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Prednimustine; Radiotherapy Dosage; Treatment Outcome; Whole-Body Irradiation | 1994 |
Mitoxantrone in combination with etoposide and prednimustine in patients older than 70 years with unfavorable non-Hodgkin's lymphoma: a prospective study in 52 patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Prednimustine; Prospective Studies; Remission Induction | 1994 |
New aspects in the treatment of advanced low-grade non-Hodgkin's lymphomas: prednimustine/mitoxantrone versus cyclophosphamide/vincristine/prednisone followed by interferon alfa versus observation only--a preliminary update of the German Low-Grade Lymphom
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Germany; Humans; Interferon-alpha; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Prednimustine; Prednisone; Vincristine | 1994 |
Continuous versus intermittent prednimustine treatment of non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednimustine | 1993 |
Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednimustine; Prognosis; Prospective Studies; Recurrence; Survival Rate | 1996 |
Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Female; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednimustine; Remission Induction; Treatment Outcome; Vincristine | 1996 |
CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Mitoxantrone; Prednimustine; Prednisone; Vincristine | 1998 |
Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Female; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednimustine; Prednisone; Prospective Studies; Survival Rate; Vincristine | 1998 |
Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednimustine; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 1998 |
A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma.
Topics: Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Prednimustine; Prognosis; Prospective Studies; Survival Analysis; Treatment Outcome | 1992 |
Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chlorambucil; Female; Humans; Lymphoma, Non-Hodgkin; Male; Metabolic Clearance Rate; Prednimustine; Prednisolone; Time Factors | 1991 |
Prednimustine treatment in malignant lymphomas.
Topics: Adult; Aged; Chlorambucil; Clinical Trials as Topic; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednimustine; Remission Induction | 1989 |
11 other study(ies) available for prednimustine and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Comprehensive geriatric assessment in elderly patients with newly diagnosed aggressive non-Hodgkin lymphoma treated with multi-agent chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Frail Elderly; Geriatric Assessment; Glyoxal; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Multivariate Analysis; Neoplasm Grading; Prednimustine; Prednisone; Prospective Studies; Republic of Korea; Treatment Outcome; Vincristine | 2015 |
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednimustine; Prednisone; Procarbazine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine | 2011 |
Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marrow; Bone Marrow Transplantation; Carmustine; Cell Survival; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Glyoxal; Graft Survival; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Multivariate Analysis; Prednimustine; Prednisolone; Prednisone; Procarbazine; Radiotherapy; Retrospective Studies; Salvage Therapy; Vinblastine; Vincristine | 1995 |
Treatment of patients with high-grade non-Hodgkin's lymphoma aged over 70 years with an all-oral regimen combining idarubicin, etoposide and alkylators.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Agranulocytosis; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Male; Prednimustine; Thrombocytopenia; Treatment Outcome | 2000 |
Prednimustine and mitoxantrone (PmM) in patients with low-grade malignant non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), and prolymphocytic leukemia (PLL).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Promyelocytic, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednimustine | 1992 |
alpha Interferon maintenance therapy in patients with low-grade non-Hodgkin's lymphomas after cytoreductive chemotherapy with prednimustine and mitoxantrone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Pilot Projects; Prednimustine; Recombinant Proteins; Salvage Therapy | 1991 |
Treatment of low-grade non-Hodgkin's lymphoma by cytoreductive chemotherapy with prednimustine/mitoxantrone followed by interferon alpha-2b maintenance: results of a clinical phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Evaluation; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Pilot Projects; Prednimustine; Recombinant Proteins; Remission Induction | 1990 |
Combination chemotherapy specifically devised for elderly patients with unfavorable non-Hodgkin's lymphoma.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednimustine; Prospective Studies; Survival Analysis | 1990 |
[Treatment of aggressive non-Hodgkin's lymphoma in aged patients with a combination of methyl-GAG, etoposide and prednimustine].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mitoguazone; Prednimustine; Survival Rate | 1990 |
Mitoxantrone in combination with prednimustine in treatment of unfavorable non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednimustine | 1988 |
Non-Hodgkin's lymphomas in the elderly: prospective studies with specifically devised chemotherapy regimens in 66 patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Podophyllotoxin; Prednimustine; Prospective Studies; Teniposide | 1987 |